Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SXTC | US
0.06
2.98%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
23/04/2026
2.12
2.11
2.13
2.06
China SXT Pharmaceuticals Inc. a pharmaceutical company engages in the research development manufacture marketing and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced fine and regular TCMP products such as ChenXiang SanQiFen HongQi SuMu JiangXiang CuYanHuSuo XiaTianWu LuXueJing XueJie ChaoSuanZaoRen HongQuMi ChuanBeiMu HuangShuKuiHua WuWeiZi DingXiang RenShen QingGuo JueMingZi and ShaRen. It provides its products under the Suxuantang Hui Chun Tang and Tong Ren Tang brands. As of March 31 2022 it had an end-customer base of 68 pharmaceutical companies 14 chain pharmacies and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou China.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
109.5%1 month
131.5%3 months
195.4%6 months
210.8%-
-
0.16
0.19
0.11
-0.36
0.41
-
-1.89M
7.37M
7.37M
-
733.81
42.60
29.50
-21.65
0.20
7.54
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.61
Range1M
1.33
Range3M
6.37
Rel. volume
0.37
Price X volume
73.70K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 1.03 | 5.71M | -2.83% | n/a | 13.20% |
| PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 2.41 | 5.37M | -3.21% | n/a | -2.89% |
| Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 0.38 | 4.65M | 1.00 | 27.85% | |
| SHPH | SHPH | Drug Manufacturers-Specialty & Generic | 0.9383 | 2.76M | 4.26% | n/a | 144.16% |
| Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 1.8 | 2.41M | -12.20% | n/a | 8.44% |
| Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 0.55 | 787.25K | 0.06 | 0.00% | |
| Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 0.2997 | 681.30K | -12.83% | n/a | 222.75% |
| Premier Biomedical Inc | BIEI | Drug Manufacturers-Specialty & Generic | 0.0005 | 549.44K | 0.00% | n/a | -22.64% |
| PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.0075 | 72.05K | 0.00% | n/a | 83.11% |
| CURE Pharmaceutical Holding Corp | CURR | Drug Manufacturers-Specialty & Generic | 3.19 | 0 | 0.63% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.52 | 7.60M | -24.64% | 0.03 | 16.03% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.355 | 5.46M | -1.39% | n/a | 422.08% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3768 | 3.52M | 0.65% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.1963 | 1.87M | -6.12% | n/a | 19.98% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0088 | 811.49K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.36 | 749.36K | -2.16% | n/a | 0.00% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 13.06 | 0 | 0.11% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.36 | 24.85 | Cheaper |
| Ent. to Revenue | 0.41 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.16 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 195.36 | 65.24 | Riskier |
| Debt to Equity | 0.19 | -1.88 | Expensive |
| Debt to Assets | 0.11 | 0.48 | Cheaper |
| Market Cap | 7.37M | 3.71B | Emerging |